Aligos Therapeutics, Inc. (ALGS)
Data as of , from SEC Form 4 filings.
See up to 3 months of ALGS. The 7-day demo opens the 1M and 3M ranges and puts ALGS on your watchlist.
Start 7-day demoLatest ALGS insider trades
- Heather PrestonGrant or award5,860 sh
- Margarita ChavezGrant or award5,860 sh
Bridget A. MartellGrant or award5,860 sh
About Aligos Therapeutics, Inc. (ALGS)
Aligos Therapeutics, Inc. files with the SEC under CIK 0001799448 and is classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
ALGS Form 4 activity by transaction type, last 90 days
No Form 4 activity for ALGS in the last 90 days.
ALGS insider transactions (Form 4)
1414 Form 4 filings on record, the earliest from Oct 10, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Heather Preston | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| Margarita Chavez | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| Bridget A. Martell | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| James Paul Scopa | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| Carole Nuechterlein | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| Peter Hirth | Grant or award | Stock Option (Right to Buy) | 5,860 | $0.00 | - | |
| Julian A. Symons - Officer | Grant or award | Stock Option (Right to Buy) | 23,310 | $0.00 | - | |
| Nikhil Aneja - Officer | Grant or award | Stock Option (Right to Buy) | 9,450 | $0.00 | - | |
| Lesley Ann Calhoun - Officer | Grant or award | Stock Option (Right to Buy) | 37,485 | $0.00 | - | |
| Lawrence Blatt - Officer | Grant or award | Stock Option (Right to Buy) | 105,840 | $0.00 | - | |
| Julian A. Symons - Officer | Grant or award | Stock Option (Right to Buy) | 16,000 | $0.00 | - | |
| Lesley Ann Calhoun - Officer | Grant or award | Stock Option (Right to Buy) | 40,185 | $0.00 | - | |
| Lawrence Blatt - Officer | Grant or award | Stock Option (Right to Buy) | 179,800 | $0.00 | - | |
| Hardean Achneck - Officer | Grant or award | Stock Option (Right to Buy) | 75,000 | $0.00 | - |
ALGS insider trading FAQ
What is the latest insider trade for ALGS?
Aligos Therapeutics, Inc. (ALGS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-29. The full record for ALGS runs to 14 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ALGS stock?
No insider purchases of ALGS were filed in the last 90 days.
How many insiders are selling ALGS stock?
No insider sales of ALGS were filed in the last 90 days.
Where can I see ALGS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ALGS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Heather Preston view on EDGAR
- - Margarita Chavez view on EDGAR
- - Bridget A. Martell view on EDGAR
- - James Paul Scopa view on EDGAR
- - Carole Nuechterlein view on EDGAR
- - Peter Hirth view on EDGAR
- - Julian A. Symons view on EDGAR
- - Nikhil Aneja view on EDGAR
- - Lesley Ann Calhoun view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ALGS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ALGS with a 7-day demo
- ALGS on your watchlist
- Every ALGS Form 4 filing on record
- Up to 3 months of ALGS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
